AIP
STRO icon

Ameritas Investment Partners’s Sutro Biopharma STRO Stock Holding History

Ameritas Investment Partners’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-662
Closed -$4.31K – 3338
2025
Q1 		$4.31K Hold
662
– – ﹤0.01% 3000
2024
Q4 		$12.2K Hold
662
– – ﹤0.01% 2852
2024
Q3 		$22.9K Buy
662
+165
+33% +$6.47K ﹤0.01% 2579
2024
Q2 		$14.6K Hold
497
– – ﹤0.01% 2761
2024
Q1 		$28.1K Hold
497
– – ﹤0.01% 2432
2023
Q4 		$21.3K Hold
497
– – ﹤0.01% 2560
2023
Q3 		$17.2K Hold
497
– – ﹤0.01% 2605
2023
Q2 		$23.1K Buy
497
+157
+46% +$7.82K ﹤0.01% 2492
2023
Q1 		$15.7K Hold
340
– – ﹤0.01% 2546
2022
Q4 		$25.6K Hold
340
– – ﹤0.01% 2452
2022
Q3 		$18K Hold
340
– – ﹤0.01% 2577
2022
Q2 		$17K Hold
340
– – ﹤0.01% 2637
2022
Q1 		$28K Hold
340
– – ﹤0.01% 2406
2021
Q4 		$51K Hold
340
– – ﹤0.01% 2119
2021
Q3 		$64K Hold
340
– – ﹤0.01% 1992
2021
Q2 		$63K Buy
340
+76
+29% +$14.9K ﹤0.01% 2034
2021
Q1 		$60K Buy
264
+42
+19% +$9.97K ﹤0.01% 1980
2020
Q4 		$48K Hold
222
– – ﹤0.01% 2017
2020
Q3 		$22K Buy
222
+74
+50% +$6.99K ﹤0.01% 2329
2020
Q2 		$12K Buy
148
+95
+179% +$9.12K ﹤0.01% 2638
2020
Q1 		$5K Hold
53
– – ﹤0.01% 2831
2019
Q4 		$6K Hold
53
– – ﹤0.01% 2883
2019
Q3 		$5K Hold
53
– – ﹤0.01% 2940
2019
Q2 		$6K Hold
53
– – ﹤0.01% 2930
2019
Q1 		$6K Hold
53
– – ﹤0.01% 2833
2018
Q4 		$5K Buy
+53
New +$6.4K ﹤0.01% 2863

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Ameritas Investment Partners's STRO Position: Q2 2025 in Review

Ameritas Investment Partners sold out of Sutro Biopharma (STRO) in Q2 2025, closing a stake of 662 shares — an estimated $4.31K sold.

Ameritas Investment Partners first reported a position in STRO in Q4 2018 and held it in 26 quarters. The position peaked at $64K in Q3 2021. 99 funds tracked by Wall St. Rank hold STRO as of Q2 2025.

  • Ameritas Investment Partners reported no remaining Sutro Biopharma position as of Q2 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 662 Sutro Biopharma shares in Q2 2025, an estimated $4.31K.
  • Ameritas Investment Partners first reported a position in Sutro Biopharma in Q4 2018 and held it in 26 quarters.
  • Ameritas Investment Partners's Sutro Biopharma position peaked at $64K in Q3 2021.
  • 99 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.